FF2-31350-77116
3 vaccinations
9 coded responses
23 check-ins
9 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 210 / MD
- Registered
- 2021-01-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-26
Registered in v-safe
-
2021-01-26
Dose 1 — Moderna
-
2021-01-26
Survey response — day 0, dose 1MedDRA: Arthralgia, Myalgia, Pain — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: I routinely experience muscle and body aches and joint pains.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-27
-
2021-01-29
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-01
-
2021-02-02
Health check-in — day 7, dose 1Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-09
Survey response — day 14, dose 1MedDRA: Balance disorder, Dizziness, Pruritus, Tinea cruris — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Worsening dizziness; worsening loss of balance; 2/08, nighttime episode of itchiness ( tinea cruris)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-16
Survey response — day 21, dose 1MedDRA: Cough — Feeling: GoodFree text: Intermittent coughing, before bed. However, it lasts only several minutes before it stops.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-23
- 2021-03-02
-
2021-03-04
Dose 2 — Moderna
- 2021-03-09
- 2021-03-10
-
2021-03-11
Health check-in — day 7, dose 2Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-18
-
2021-03-25
Survey response — day 21, dose 2MedDRA: Nausea — Feeling: FairFree text: Momentary nausea; before bedtime last night; twice within 10-12 min; subsided without any vomiting.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-03
- 2021-04-08
- 2021-04-15
-
2021-06-03
Survey response — 3 months, dose 2MedDRA: Dizziness — Feeling: Fair · Be unable to do your normal daily activitiesFree text: 3-4 brief episodes of dizziness or lightheadedness when going to bed.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-09-02
Survey response — 6 months, dose 2MedDRA: Dizziness, Dizziness postural — Feeling: FairFree text: Momentary light-headedness or dizziness upon rising out of bed. I am not aware of any other transitory symptoms.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-12-16
Dose 3 — ModernaCo-administered: Flu
-
2022-03-06
Survey response — 12 months, dose 2MedDRA: Chronic obstructive pulmonary disease, Pain, Sleep apnoea syndrome — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Not related to Covid-19; more akin to aging, COPD, sleep apnea.MedDRA releases: 2024-11 · check-in free text available
-
2022-03-06
Report sent to call center — 12 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-03-09
Call successfulNot applicable - Accidental Reporting
- 2022-03-17
-
2022-06-16
Survey response — 6 months, dose 3MedDRA: Cognitive disorder, General physical health deterioration, Hypoacusis, Insomnia, Pruritus, Quality of life decreased, Visual impairment — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: General physical decline and cognitive decline. Pronounced bouts of itchiness, which are affecting healthful sleep. Vision and hearing are worsening ... affects Quality of Life.MedDRA releases: 2024-11 · check-in free text available
-
2022-06-16
Report sent to call center — 6 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-06-17
Call successfulNot applicable - Accidental Reporting
-
2022-12-16
Survey response — 12 months, dose 3MedDRA: Corrective lens user, Dizziness, Encopresis, Enuresis, Visual impairment — Feeling: FairFree text: Momentary dizziness; vision-need new lenses; vision is dimmer; increased occurrences of enuresis and encopresisMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-26 | Moderna | |
| 2 | 2021-03-04 | Moderna | |
| 3 | 2021-12-16 | Moderna | Flu |
Call center
2 call center cases
2 successful
Free text
Release 2 — day 0, dose 1
Systemic reaction (other): I routinely experience muscle and body aches and joint pains.
Release 3 — day 14, dose 1
Symptoms: Worsening dizziness; worsening loss of balance; 2/08, nighttime episode of itchiness ( tinea cruris)
Release 4 — day 21, dose 1
Symptoms: Intermittent coughing, before bed. However, it lasts only several minutes before it stops.
Release 6 — day 21, dose 2
Symptoms: Momentary nausea; before bedtime last night; twice within 10-12 min; subsided without any vomiting.
Release 8 — 3 months, dose 2
Symptoms: 3-4 brief episodes of dizziness or lightheadedness when going to bed.
Release 9 — 6 months, dose 2
Symptoms: Momentary light-headedness or dizziness upon rising out of bed. I am not aware of any other transitory symptoms.
Release 11 — 12 months, dose 2
Symptoms: Not related to Covid-19; more akin to aging, COPD, sleep apnea.
Release 12 — 6 months, dose 3
Symptoms: General physical decline and cognitive decline. Pronounced bouts of itchiness, which are affecting healthful sleep. Vision and hearing are worsening ... affects Quality of Life.
Release 12 — 12 months, dose 3
Symptoms: Momentary dizziness; vision-need new lenses; vision is dimmer; increased occurrences of enuresis and encopresis
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Balance disorder | ✓ | ✓ | ✓ |
| SD | Chronic obstructive pulmonary disease | · | · | ✓ |
| SD | Cognitive disorder | · | · | ✓ |
| SD | Corrective lens user | · | · | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Dizziness postural | ✓ | · | ✓ |
| SD | Encopresis | · | · | ✓ |
| SD | Enuresis | · | · | ✓ |
| SD | General physical health deterioration | · | · | ✓ |
| SD | Hypoacusis | · | · | ✓ |
| SD | Insomnia | · | · | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pruritus | ✓ | ✓ | ✓ |
| SD | Quality of life decreased | · | · | ✓ |
| SD | Sleep apnoea syndrome | · | · | ✓ |
| SD | Tinea cruris | ✓ | ✓ | ✓ |
| SD | Visual impairment | · | · | ✓ |
| SRO | Arthralgia | ✓ | ✓ | ✓ |
| SRO | Myalgia | ✓ | ✓ | ✓ |
| SRO | Pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release